Clinical Trial Update: PROACTIVE-HF IDE Trial Heart Failure NYHA Class III [NA]

View source ↗

Summary

Update on the PROACTIVE-HF IDE trial for heart failure (NYHA Class III). The study is currently active but not recruiting, and results were posted on March 3, 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Endotronix, Inc. | Conditions: Heart Failure NYHA Class III | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-03-03